Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations

M. Golam Mohi(Beth Israel Deaconess Medical Center), Ifor R. Williams(Emory University), Charles R. Dearolf(Massachusetts General Hospital), Gordon Chan(Beth Israel Deaconess Medical Center), Jeffery L. Kutok(Brigham and Women's Hospital), Sarah L. Cohen(Brigham and Women's Hospital), Kelly Morgan(Brigham and Women's Hospital), Christina Boulton(Brigham and Women's Hospital), Hirokazu Shigematsu(Dana-Farber Cancer Institute), Heike Keilhack(Beth Israel Deaconess Medical Center), Koichi Akashi(Dana-Farber Cancer Institute), D. Gary Gilliland(Brigham and Women's Hospital), Benjamin G. Neel(Beth Israel Deaconess Medical Center)
Cancer Cell
February 1, 2005
Cited by 276Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis